137 related articles for article (PubMed ID: 36569710)
1. The Pattern of Heparin Dosing as Venous Thromboembolism Prophylaxis in Adult Underweight Patients Admitted to Critical Care Units at a Tertiary Hospital.
Al Harthy N; Al Harthi F; Al Harb S; Al Dughayem N; Al Harthi K; Gramish J
Cureus; 2022 Nov; 14(11):e31717. PubMed ID: 36569710
[TBL] [Abstract][Full Text] [Related]
2. Practice Patterns of Venous Thromboembolism Prophylaxis in Underweight, Critically Ill Patients with Neurologic Injury.
Betthauser K; Pope H; Gowan M; Human T
Neurocrit Care; 2017 Aug; 27(1):96-102. PubMed ID: 28097621
[TBL] [Abstract][Full Text] [Related]
3. Comparison between standard Vs. Escalated dose venous thromboembolism (VTE) prophylaxis in critically ill patients with COVID-19: A two centers, observational study.
Aljuhani O; Al Sulaiman K; Hafiz A; Eljaaly K; Alharbi A; Algarni R; Al Homaid S; Kahtani K; Alsulaiman T; Vishwakarma R; Al Ghamdi G; Alalawi M; Korayem GB
Saudi Pharm J; 2022 Apr; 30(4):398-406. PubMed ID: 35136364
[TBL] [Abstract][Full Text] [Related]
4. Clinical Experience With Pharmacological Venous Thromboembolism Prophylaxis in the Underweight and Critically Ill.
Carter C; Bushwitz J; Gowan M; Pope H; Human T; Gibson G; Owen E; Hampton N; Whitman C
Ann Pharmacother; 2016 Oct; 50(10):832-9. PubMed ID: 27371544
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of standard dose unfractionated heparin for venous thromboembolism prophylaxis in morbidly obese and non-morbidly obese critically Ill patients.
Lee YR; Blanco DD
J Thromb Thrombolysis; 2017 Oct; 44(3):386-391. PubMed ID: 28828713
[TBL] [Abstract][Full Text] [Related]
6. Prevention of venous thromboembolism in critically ill medical patients: a Franco-Canadian cross-sectional study.
Lacherade JC; Cook D; Heyland D; Chrusch C; Brochard L; Brun-Buisson C;
J Crit Care; 2003 Dec; 18(4):228-37. PubMed ID: 14691896
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism prophylaxis in the critically ill: a point prevalence survey of current practice in Australian and New Zealand intensive care units.
Robertson MS; Nichol AD; Higgins AM; Bailey MJ; Presneill JJ; Cooper DJ; Webb SA; McArthur C; MacIsaac CM; ;
Crit Care Resusc; 2010 Mar; 12(1):9-15. PubMed ID: 20196708
[TBL] [Abstract][Full Text] [Related]
8. Venous Thromboembolism Prophylaxis in Underweight Hospitalized Patients.
Buckheit D; Lefemine A; Sobieraj DM; Hobbs L
Clin Appl Thromb Hemost; 2021; 27():10760296211018752. PubMed ID: 34080451
[TBL] [Abstract][Full Text] [Related]
9. The use of enoxaparin as venous thromboembolism prophylaxis in bariatric surgery: A retrospective cohort study.
Altawil E; Alkofide H; Almohaini H; Alobeed A; Alhossan A
Saudi Pharm J; 2022 Oct; 30(10):1473-1478. PubMed ID: 36387338
[TBL] [Abstract][Full Text] [Related]
10. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
[TBL] [Abstract][Full Text] [Related]
11. A multicentre controlled pre-post trial of an implementation science intervention to improve venous thromboembolism prophylaxis in critically ill patients.
Stelfox HT; Brundin-Mather R; Soo A; Parsons Leigh J; Niven DJ; Fiest KM; Doig CJ; Zuege DJ; Kushner B; Clement F; Straus SE; Cook DJ; Bagshaw SM; Sauro KM
Intensive Care Med; 2019 Feb; 45(2):211-222. PubMed ID: 30707246
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the use of low-molecular-weight heparin for venous thromboembolism prophylaxis in medical patients.
Du Plessis JA; Van Blydenstein SA; Wong M
S Afr Med J; 2020 Feb; 110(3):235-242. PubMed ID: 32657702
[TBL] [Abstract][Full Text] [Related]
13. Assessing, preventing, and treating venous thromboembolism: evidence-based approaches.
Nutescu EA
Am J Health Syst Pharm; 2007 Jun; 64(11 Suppl 7):S5-13. PubMed ID: 17519445
[TBL] [Abstract][Full Text] [Related]
14. Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center.
Tinsley A; Naymagon S; Enomoto LM; Hollenbeak CS; Sands BE; Ullman TA
J Crohns Colitis; 2013 Dec; 7(12):e635-40. PubMed ID: 23706933
[TBL] [Abstract][Full Text] [Related]
15. Enoxaparin versus tinzaparin for venous thromboembolic prophylaxis during rehabilitation after acute spinal cord injury: a retrospective cohort study comparing safety and efficacy.
Marciniak CM; Kaplan J; Welty L; Chen D
PM R; 2012 Jan; 4(1):11-7. PubMed ID: 22269449
[TBL] [Abstract][Full Text] [Related]
16. Venous Thromboembolism Prophylaxis: A Narrative Review With a Focus on the High-Risk Critically Ill Patient.
Lewis TC; Cortes J; Altshuler D; Papadopoulos J
J Intensive Care Med; 2019; 34(11-12):877-888. PubMed ID: 30165770
[TBL] [Abstract][Full Text] [Related]
17. Prophylaxis against venous thromboembolism in acutely ill medical patients: an observational study.
Peterman CM; Kolansky DM; Spinler SA
Pharmacotherapy; 2006 Aug; 26(8):1086-90. PubMed ID: 16863485
[TBL] [Abstract][Full Text] [Related]
18. European guidelines on perioperative venous thromboembolism prophylaxis: Surgery in the elderly.
Kozek-Langenecker S; Fenger-Eriksen C; Thienpont E; Barauskas G;
Eur J Anaesthesiol; 2018 Feb; 35(2):116-122. PubMed ID: 28901992
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and Safety of Twice Daily Versus Thrice Daily Subcutaneous Unfractionated Heparin for Venous Thromboembolism Prophylaxis at a Tertiary Medical Center.
Sorgi MW; Roach E; Bauer SR; Bass S; Militello M; Welch S; Lam S; Reddy AJ; Torbic H
J Pharm Pract; 2022 Apr; 35(2):190-196. PubMed ID: 33016183
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients.
Rothberg MB; Pekow PS; Lahti M; Lindenauer PK
J Hosp Med; 2012; 7(6):457-63. PubMed ID: 22473716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
